publication venue for
- A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.. -. 2021
- The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).. 38:1184-90. 2014
- The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes.. 36:1370-5. 2012
- Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes.. 35:904-8. 2010
- Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes.. 33:1594-8. 2009
- MicroRNA modulation of megakaryoblast fate involves cholinergic signaling.. 30:583-95. 2005
- Runx1/AML1 in leukemia: disrupted association with diverse protein partners.. 26:221-8. 2002
- Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.. 14:895-903. 1990